scholarly journals Effects of Stellate Ganglion Block Through Different Approaches Under Guidance of Ultrasound

2022 ◽  
Vol 8 ◽  
Author(s):  
Hai-Hua Shan ◽  
Hong-Fang Chen ◽  
Yong Ni ◽  
Jia-Xuan Yang ◽  
Xue-Lan Zhou
Keyword(s):  
Adverse Reactions ◽  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Cervical Vertebra ◽  
Transverse Process ◽  
Research Subjects ◽  
Ganglion Block ◽  
Significant Difference ◽  
Operation Duration ◽  
The Difference

ObjectiveThis study aimed to investigate the effects of stellate ganglion block (SGB) through different approaches under guidance of ultrasound.MethodsA total of 130 patients undergoing SGB in our hospital between February 2019 and February 2020 were enrolled as the research subjects. According to the random number table method, these subjects were divided into two groups: a modified 6th cervical vertebra (C6) group (n = 65) and a 7th cervical vertebra (C7) group (n = 65). Under the guidance of ultrasound, the subjects in the modified C6 group were punctured at the level of the C6 transverse process, and the subjects in the C7 group were punctured at the level of the C7 transverse process. The operation duration, number of puncture angle adjustments, block effects, and adverse reactions for SGB were compared between the two groups.ResultsThe modified C6 group showed shorter SGB operation duration and a lower number of puncture angle adjustments than the C7 group, and the differences were statistically significant (P < 0.05). Horner Syndrome occurred in both groups after SGB. The incidence of adverse reactions in the modified C6 group was 4.62%, comprising 1 case of hoarseness and 2 cases of slowed pulse, while that in the C7 group was 6.15%, with 1 case of hoarseness and 3 cases of slowed pulse; the difference between the two groups was not statistically significant (P > 0.05).ConclusionThe operation duration for modified SGB guided by ultrasound puncturing at the C6 transverse process is shorter and requires fewer puncture angle adjustments than puncturing at the C7 transverse process; however, there is no significant difference between the incidence of adverse reactions or the blocking effects of the two methods.

Variable Osteology of the Sixth Cervical Vertebra in Relation to Stellate Ganglion Block

2008 ◽  
Vol 33 (2) ◽  
pp. 102-108 ◽  
Author(s):  
James E. Janik ◽  
Mark A. Hoeft ◽  
Amir H. Ajar ◽  
Gary F. Alsofrom ◽  
Michael T. Borrello ◽  
...  
Keyword(s):  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Cervical Vertebra ◽  
Ganglion Block

Variable Osteology of the Sixth Cervical Vertebra in Relation to Stellate Ganglion Block

2008 ◽  
Vol 33 (2) ◽  
pp. 102-108
Author(s):  
J JANIK ◽  
M HOEFT ◽  
A AJAR ◽  
G ALSOFROM ◽  
M BORRELLO ◽  
...  
Keyword(s):  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Cervical Vertebra ◽  
Ganglion Block

scholarly journals Do not follow the bone, follow the nerve ultrasound-guided stellate ganglion block: a reconfirmation

2019 ◽  
Vol 13 (4) ◽  
pp. 226-229 ◽  
Author(s):  
Dalia H Elmofty ◽  
Maxim Eckmann
Keyword(s):  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Direct Methods ◽  
Transverse Process ◽  
Ultrasound Guided ◽  
Nerve Ultrasound ◽  
Ganglion Block ◽  
Nerve Roots ◽  
Technical Challenge

Indirect and direct methods have been used to localize the stellate ganglion. Identifying the C6 and C7 transverse process can be a technical challenge for practitioners when performing an ultrasound-guided stellate ganglion block. Following the nerve roots from the interscalene plexus into the corresponding foramen can serve as a reconfirmation for identifying the C6 and C7 transverse process.

scholarly journals Several aspects of stellate ganglion block

Pain medicine ◽  
2018 ◽  
Vol 3 (2) ◽  
pp. 62-66
Author(s):  
E. P. Yevstratov ◽  
N. V. Krupskaya ◽  
V. Y. Shumlyanskiy
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Cluster Headache ◽  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Resistive Index ◽  
Ganglion Block ◽  
Ultrasound Technique ◽  
Blood Flow Reduction ◽  
The Difference

Background and Study Goal. Stellate ganglion block (SGB) has been used in the treatment of cerebral derangements associated with headache, for the purpose of reliving spasm and presumably increasing the cerebral blood flow, normalizing endovascular resistance. Materials and Methods. 30 volunteers underwent unilateral SGB, 30–40 years (21 females, 9 males), with cluster headache. 5 ml 0,25 % ropivacaine were administered + 4 mg dexamethasone under C6 level paratracheal ultrasound guid. The confirmation was the presence of Horner´s syndrome. The resistive index (RI) was measured by ultrosound transcranial CV doppler of middle cerebral artery at the baseline and 1 min, and 10 min after SGB on both sides (the other side was taken for control). Normal values of RI corresponded to the age. Results and discussion. Our observations showed that after SGB in all patients there was a significant change in RI with normalization of cerebral blood flow, reduction or disappearance of headache. Conclusions. The difference between the block and the nonblock sides was significant before procedure (p < 0,0001) and after 10 min become the same with an insignificant difference (p = 0,001). A higher RI in patients with a cluster headache may be as an indicator for choosing the block side. Ultrasound technique will be helpfull for providing safe block and effect control.

scholarly journals Comparison Between the Effectiveness of Complex Decongestive Therapy and Stellate Ganglion Block in Patients with Breast Cancer-Related Lymphedema: A Randomized Controlled Study

2018 ◽  
Vol 3 (22;3) ◽  
pp. 255-263
Author(s):  
Kwan Sik Seo
Keyword(s):  
Breast Cancer ◽  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Ganglion Block ◽  
Complex Decongestive Therapy ◽  
Significant Difference ◽  
Breast Cancer Related Lymphedema ◽  
Eq Vas ◽  
Decongestive Therapy

Background: Breast cancer-related lymphedema (BCRL) of the upper extremities often follows breast cancer treatment. Although complex decongestive therapy (CDT) is currently the standard treatment for BCRL, stellate ganglion block (SGB) has also been reported to be effective. Objectives: This study aimed to determine the effectiveness of SGB in the treatment of BCRL, and to assess the impact of the treatment on the quality of life (QoL) compared to CDT. Study Design: A randomized controlled trial. Setting: A single academic hospital, outpatient setting. Methods: A total of 38 patients with BCRL were recruited. Patients were randomly divided into 2 groups. Patients enrolled in the CDT group underwent 10 sessions of CDT for 2 weeks, whereas patients in the SGB group received 3 consecutive SGBs every 2 weeks. Changes in circumference, volume, and bioimpedance in the upper extremity were measured at baseline and 2 weeks after treatment and compared between the 2 groups. EuroQol-5 dimensions (EQ-5D) and EuroQol visual analog scale (EQ VAS) for QoL and subjective improvement were monitored. Results: In both groups, side-to-side difference of circumference after the treatment was decreased significantly from baseline (P < 0.05), and side-to-side difference of volume was reduced significantly in the SGB group (P < 0.05). No statistically significant difference was noted in the treatment effect between the 2 groups. Results of the EQ-5D, EQ VAS, and questionnaires regarding subjective symptoms administered at baseline and 2 weeks after each intervention revealed no statistically significant difference in the treatment effects between CDT and SGB. Limitations: Further long-term follow-up studies with a greater number of patients that include analysis according to the severity and duration of symptoms are needed. Conclusions: The results of this study suggest that SGB is an effective treatment for BCRL and may be considered as an alternative to CDT. Key words: Stellate ganglion block, complex decongestive therapy, breast cancer, lymphedema, breast cancer-related lymphedema, quality of life, bioimpedance, secondary lymphedema

scholarly journals Effects of Stellate Ganglion Block on Breast Cancer-Related Lymphedema: Comparison of Various Injectates

2015 ◽  
Vol 18;1 (1;1) ◽  
pp. 93-99
Author(s):  
Jeetinder Kaur Makkar
Keyword(s):  
Breast Cancer ◽  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Ganglion Block ◽  
Upper Arm ◽  
Subjective Data ◽  
Arm Circumference ◽  
Significant Difference ◽  
Group A ◽  
Breast Cancer Related Lymphedema

Background: Stellate ganglion block (SGB) has been reported to be effective in the treatment of breast cancer-related lymphedema (BCRL). Objective: To determine the effects of SGB in BCRL patients and the efficacy of corticosteroids in SGB. Study Design: A double-blinded, randomized, controlled trial. Setting: A single academic hospital, outpatient setting. Methods: In total, 32 patients with BCRL were recruited. Patients were divided randomly into 3 groups (Group A: 0.5% bupivacaine 5 mL, n = 12; Group B: 0.5% bupivacaine 4.5 mL + 20 mg of triamcinolone 0.5 mL, n = 10; and Group C: 0.5% bupivacaine 4 mL + 40 mg of triamcinolone 1 mL, n = 10). All patients received 3 consecutive SGBs, every 2 weeks. The primary outcomes were changes in forearm and upper arm circumference. Circumference was measured at baseline, 2 weeks (before the second injection), 4 weeks (before the third injection), and 8 weeks (one month follow-up after 3 consecutive SGBs). Moreover, subjective data were collected using EORTC C-30 at baseline and 8 weeks. Results: After 3 consecutive SGBs, forearm and upper arm circumferences were decreased significantly from baseline in all groups (P < 0.05/3). The upper arm circumference of group C was reduced significantly more than that of group A (P < 0.05/3). The subjective data by EORTC-C30 at baseline and one month after 3 consecutive SGBs revealed no statistically significant difference. Limitations: Relatively few patients were enrolled. We did not compare SGB with any other BCRL treatment, such as complex decongestive therapy. Conclusions: This study suggests that SGB may be an effective treatment for BCRL. Furthermore, it appears that corticosteroids could have an additive effect in SGB. Key words: Stellate ganglion block, breast cancer, lymphedema:

scholarly journals Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children

2019 ◽  
Vol 36 (2) ◽  
Author(s):  
Rui Han ◽  
Qianqian Yu ◽  
Guohui Zhang ◽  
Baoqiang Li ◽  
Shuzhen Han ◽  
...  
Keyword(s):  
Adverse Reactions ◽  
Clinical Symptoms ◽  
Control Group ◽  
Clinical Effects ◽  
Observation Group ◽  
Research Subjects ◽  
Creative Commons ◽  
Significant Difference ◽  
Mycoplasma Pneumonia ◽  
The Difference

Objective: To study and compare the clinical effects of azithromycin and erythromycin on children with mycoplasma pneumonia. Methods: Total 132 children with mycoplasma pneumonia who were admitted to our hospital between November 2017 and September 2018 were selected as the research subjects. All the children were divided into an observation group and a control group according to random number table, 66 each. The observation group was treated with azithromycin, while the control group was treated with erythromycin. The therapeutic effect, incidence of adverse reactions and disappearance time of clinical symptoms were compared between the two groups. Results: The total efficacy of the observation group was 98.04%, and that of the control group was 74.51%; there was a significant difference (X2=7.184, P=0.007). The incidence of adverse reactions in the observation group was 15.69%, significantly lower than that in the control group (41.18%) (X2=6.376, P=0.002). The disappearance of fever, cough, rale and X ray shadow of the observation group was significantly earlier than that of the control group, and the difference was statistically significant (P<0.05). Conclusion: Compared with erythromycin, azithromycin is more effective in the treatment of mycoplasma pneumonia in children. Azithromycin can further shorten the improvement time of clinical symptoms and signs and has few adverse reactions and high safety. It is worth clinical application. doi: https://doi.org/10.12669/pjms.36.2.1441 How to cite this:Han R, Yu Q, Zhang G, Li B, Han S, Li G. Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children. Pak J Med Sci. 2020;36(2):---------. doi: https://doi.org/10.12669/pjms.36.2.1441 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Sign in / Sign up

Export Citation Format

Share Document